For cblC-MMA patients (Fig. 2), multivariate analysis revealed that “pre-treatment onset” (OR = 8.62–26.7) and “NBS” (OR = 0.03–0.42) were independent predictors of nearly all analyzed poor prognostic manifestations except death and anemia. Here, CBLC is linked to anemia.